Key Corporate Account Director - Northeast

PharmaEssentia U.S.A.•Burlington, MA

2d•Remote

About The Position

PharmaEssentia Corporation is a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one product approved and a diversifying pipeline. We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taiwan Stock Exchange (TWSE: 6446) and are expanding our global presence with operations in the U.S., Japan, Singapore, South Korea, and China, along with a world-class biologics production facility in Taichung. The Key Corporate Account Director (KCAD) is responsible for strategic customer engagement and access execution across an assigned geographic territory that includes large community oncology clinics, oncology provider networks, specialty GPO member organizations, and NCI‑designated/NCCN member academic cancer centers and academic medical centers. The KCAD operates across both GPO‑driven network environments and institutional academic health systems, partnering with complex, multi‑level stakeholders to develop and execute account‑specific access strategies, implement institutional access plans, and proactively navigate formulary, systems, and process challenges that impact product availability. A core focus of the role is building deep account expertise and durable stakeholder relationships to ensure PharmaEssentia products are: Accessible within health system and/or oncology provider networks and clinics Accurately represented in clinical and administrative systems Appropriately embedded within the clinical workflows physicians use to treat patients The KCAD does not generate HCP prescribing demand. Instead, the role ensures the organizational and institutional conditions for demand are in place, enabling seamless operational or access processes for all customer segments. This is achieved through targeted engagement with healthcare decision makers who influence contracting, formularies, pathways, and ordering and dispensing infrastructure. The KCAD’s responsibilities span core access pillars: GPO contracting and pull‑through execution across community oncology and network‑based accounts Optimize Access through Oncology Optimized Limited Distribution model Influence of clinical systems and ordering infrastructure, including formularies, pathways, EMR ordering, and decision‑support tools to create organizational demand Strategic stakeholder engagement and institutional communications across medical, pharmacy, population health, and administrative leadership Market access insights generated through customer engagement, data analysis, and cross‑functional collaboration with Sales, Marketing, Medical Affairs, and Market Access partners are central to driving effective account planning, informing enterprise strategy, and aligning execution across the field organization. The KCAD reports to the Senior Director, Corporate Accounts & GPO Strategy.

Requirements

Bachelor’s degree required with 5+ years of pharmaceutical or biotech experience in corporate accounts, market access, or oncology account management, including 3+ years supporting oncology products
Experience engaging community oncology networks, GPO member accounts, and/or health system/IDN customers
Demonstrated ability to effectively engage both commercial stakeholders (GPO and network executives, contracting and access leaders) and clinical stakeholders (pharmacy directors, clinical pharmacists, pathway and P&T committee members) using data‑driven clinical and economic evidence
Experience working with population health decision makers and senior leaders within complex health systems and oncology medical organizations
Strong understanding of GPO contracting mechanics, pull‑through strategies, in‑office/medically integrated dispensing (IOD/MID), distribution and wholesaler channels, pricing and chargeback structures, buy‑and‑bill vs pharmacy benefit dynamics, 340B eligibility, and health system–owned specialty pharmacies
Excellent written and verbal communication skills, with strong negotiation capability, business acumen, and analytical skills
Ability to travel approximately 50%, with residence in proximity to a major airport

Nice To Haves

Advanced degree preferred (MBA, PharmD, or relevant clinical/scientific degree)
Experience working with large community oncology provider networks and oncology stakeholder organizations
Familiarity with oncology clinical pathway tools, EMR ordering systems, and formulary management processes, including pathway pull‑down platforms and clinical decision support tools
Experience working with NCI‑designated and/or NCCN member academic cancer centers, including exposure to health system specialty pharmacy, institutional P&T and formulary review processes
Established relationships with oncology GPO member accounts or network leadership within the assigned geography
Experience reviewing and synthesizing clinical literature, disease‑state data, and NCCN guidelines to inform access strategy and stakeholder engagement

Responsibilities

Support launch planning and ongoing access strategy for current and future products by developing and executing account‑level access plans across community oncology networks, GPO member accounts, and NCI‑designated/NCCN academic cancer centers within the assigned territory.
Inform and execute GPO contract strategy within assigned accounts, including contract negotiation, launch initiatives, and pull-through activity to ensure contracted accounts are actively utilizing and ordering PEC products through the appropriate channel.
Lead engagement with population health and account decision makers—including medical, quality, pharmacy, specialty pharmacy, clinical, P&T, pathway, and ordering system stakeholders—to communicate clinical and economic value and secure appropriate formulary, EMR, and pathway inclusion for PEC products.
Educate and support customers who own clinical decision tools, ordering systems, and pathways to ensure accurate representation of PEC products, recognizing that these tools are owned and maintained by the customer.
Compliantly align and collaborate with cross‑functional partners (sales, medical affairs, market access, and marketing) to deliver a coordinated customer engagement strategy and support optimal product access across the portfolio.
Identify account‑level access barriers and competitive threats and develop response strategies in collaboration with the broader market access team to resolve issues and protect access within assigned accounts.
Serve as the primary corporate accounts resource for field sales teams, providing account intelligence, resolving access challenges, and supporting pull‑through and utilization efforts.
Establish and maintain a deep understanding of key account needs, priorities, and market dynamics; synthesize and communicate actionable customer and industry insights to internal stakeholders.
Identify and support opportunities and programs in collaboration with national oncology stakeholder groups and actively participate in relevant customer and industry meetings.
Maintain accurate, up‑to‑date account plans, CRM documentation, and KPI tracking across all assigned accounts.